TOP BIOLOGY TECHNOLOGY
Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology
Biology NewsMedicine NewsBiology ProductsMedicine ProductsBiology DefinitionMedicine DefinitionBiology TechnologyMedicine TechnologyBiology DictionaryMedicine Dictionary
The top biology technology of this week
Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
| 11/18/2009 | RICHMOND, Calif., Nov. 18 /- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were inadvertently and prematurely disclosed on the internet. Data were presented in a student course... [Comments] |
Hungarian Cancer Formula Producer Questions U.S. Introduction of AveUltra
| 11/17/2009 | BUDAPEST, Hungary, Nov. 17 /- Hungarian drug producer Biropharma and patent holders of its main product Avemar dispute the connection American BioSciences Inc. and its partner Mate Hidvegi are making between their recently introduced product AveUltra and Avemar, a dietary supplement being used in cancer treatment internationally for 11 years. "AveUltra and Avemar a... [Comments] |
| 11/20/2009 | AUDIO: A team of scientists from Washington University in St. Louis, the University of Arizona, Cold Spring Harbor Laboratory and Iowa State University has finished sequen... [Comments] |  |
Spanish biotechnology should focus on food and plant sectors to be more competitive
| 11/20/2009 | Spain and Latin American countries have an opportunity to take the lead in two small biotechnology sectors. Researchers from the University of Valencia (UV), working together with the IDICHUS Foundation, have studied the productive fabric of the Spanish biotechnology industry. Their conclusion i... [Comments] |  |
Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category
| 11/20/2009 | SAN DIEGO, Nov. 20 /- Veridiam (www.veridiam.com) won the prestigious Crystal Award in the mid-size company category at the 2009 Workplace Excellence Awards. The awards are sponsored by the San Diego Society for Human Resources Management and recognize innovative and exceptional human resources practices. Veridiam was one of nine winners, selected from more than 129... [Comments] |
| 11/17/2009 | CALGARY, Nov. 17 / Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" or the "Company") today announced updated results from a Phase I/II U.K. trial (REO 011) of REOLYSIN(R) combined with paclitaxel/carboplatin for patients with advanced cancers in a poster presentation at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference b... [Comments] |
deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court
| 11/24/2009 | REYKJAVIK,Iceland,November24FirstCall/--deCODEgenetics,Inc.(Nasdaq: DCGN )todayannouncedtheapprovalofallofits"firstday"motionsbytheU.S.BankruptcyCourtfortheDistrictofDelaware(the"BankruptcyCourt").deCODElastweekfiledavoluntarypetitionforreliefunderChapter11oftheUnitedStatesBankruptcyCodewiththeBankruptcyCourt. TheordersissuedbytheBankruptcyCourtallowthecompanytoco... [Comments] |
US Patent Allowed for NOD Tech
| 11/24/2009 | SHANGHAI,Nov.24Asia/--NODPharmaceuticalsInc.announcedtheUSPatent&TrademarkOffice(PTO)hasallowedthepatentapplicationforitsnano-particleoraldeliveryorNODtechnology. NODtechnologyisahighlyefficientapproachtoincorporatepeptidesorproteinsintobio-adhesivenano-particlestoenableoraldeliveryofdrugsotherwiseadministeredasinjections.NODtechnologyisaplatformtechnologythat... [Comments] |
NeurogesX to Present at Piper Jaffray Health Care Conference
| 11/24/2009 | SANMATEO,Calif.,Nov.24FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopharmaceuticalcompanyfocusedondevelopingandcommercializingnovelpainmanagementtherapies,announcedtodaythatAnthonyDiTonno,PresidentandChiefExecutiveOfficer,isscheduledtopresentatthe21stAnnualPiperJaffrayHealthCareConference,tobeheldDecember1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. Mr.DiTonnoandSte... [Comments] |
Biolaxy Secures IND Approval for Oral Insulin
| 11/24/2009 | SHANGHAI,Nov.24Asia/--ShanghaiBiolaxyannouncedtheChineseStateFood&DrugAdministration(SFDA)hasapprovedtheinvestigationalnewdrugapplication(IND)foritsoralinsulinproject(Nodlin),aninnovativeinsulinformulationtotreatdiabetes.ThisINDapprovalallowsBiolaxytoinitiateitsfirstphaseIclinicalstudy. Diabetesisadisordercharacteristicofhighbloodglucoseandpoormetabolism.Theco... [Comments] |
Top BIO technology of this month
[3]RNL BIO Rescues a College Student from Autoimmune Hearing Loss[3]Soligenix to Present at 8th Annual BIO Investor Forum[2]Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS[2]Hungarian Cancer Formula Producer Questions U.S. Introduction of AveUltra[2]Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing[2]Fertili-Plus Introduces 5-Step Conception Framework[2]BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes[1]Amaizing: Corn genome decoded[1]Spanish biotechnology should focus on food and plant sectors to be more competitive[1]Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category[1]Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting[1]Berkeley researchers take the lead out of piezoelectrics[1]DuPont Receives Corporate Innovation Award[1]Soligenix Reports Third Quarter 2009 Financial Results[1]Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference[1]New nanocrystalline diamond probes overcome wear[1]Cellerix Raises EUR27 Million in a First Closing[1]Amedica Announces New Product Offering[1]CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response[1]Microbix Biosystems Re-files Annual Results With OSC
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |